Share Name Share Symbol Market Type Share ISIN Share Description
Puretech Health LSE:PRTC London Ordinary Share GB00BY2Z0H74 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +4.00p +2.60% 158.00p 157.00p 159.00p 162.00p 157.00p 160.00p 98,494 16:35:06
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Financial 1.9 -52.4 9.6 16.3 446.24

Puretech Share Discussion Threads

Showing 201 to 222 of 225 messages
Chat Pages: 9  8  7  6  5  4  3  2  1
DateSubjectAuthorDiscuss
25/5/2018
12:24
nice option award for the cfo!
edwardt
09/5/2018
16:56
restorbio = also finding a floor in the states. i wish i had a bit more cash...
edwardt
09/5/2018
09:14
help. i clearly have this wrong but want to show my logic. what is puretech's value in akili post the raise announced this morning? we know that they owned 54.3% at end of 17 and now fully diluted position is 40.3%. They did not participate in raise. hence my maths would imply that if all existing shareholders were diluted too, the valuation of akili's equity is circa 27% diluted. Hence the tev would be $203m. Hence we can notionally value puretech's stake at $80m which is probably still at a meaningful discount as and when it ipos. anyone think my maths is totally wrong?
edwardt
30/4/2018
10:38
well if that happens my hair will stand on end...
edwardt
26/4/2018
19:01
You'll be able to afford all those shares once Follica makes PRTC pop to 1B+
saleen230
26/4/2018
14:40
maybe new fd? it certainly wasn't me (unfortunately!)
edwardt
25/4/2018
20:18
Any idea who bought 250,000 shares?
saleen230
18/4/2018
23:58
Plus interesting that the recent placing mentions puretech and lighthouse capital proving Follica $11.79m of debt, they must have some confidence.
lendmeafiver
18/4/2018
23:42
It’s also worth reading the original IPO wording on Follica page 105 onwards, provides some interesting detail.
lendmeafiver
18/4/2018
20:34
Thanks for the link Dr. Anderson is truly a genious. I have the same view on Follica and frankly enough this is the main reason I keep adding more to my position
saleen230
18/4/2018
19:28
At £380m market cap puretech is in my view hugely undervalued when looking at the pipeline excluding Follica. If Follica works, which given the team behind it is possible, then heaven knows what that business would be worth. Have a read of this: www.bostonglobe.com/business/2017/04/14/meet-one-most-important-medical-entrepreneurs-you-never-heard/dfZFRbcdtjLcqyxci9vKlM/story.html
lendmeafiver
18/4/2018
18:52
Why all this selling did I miss something? Also what are your guys thoughts about Follica?
saleen230
18/4/2018
11:26
the two are normally inversely linked in terms of resulting performance from my experience lend me.
edwardt
17/4/2018
16:28
Very well written and presented report and so much upside potential here, amazes me there are not more here or on any of the other online discussion boards.
lendmeafiver
17/4/2018
13:29
lots of content and detail in the report - would love to understand more on the science but have resigned myself to that long ago. on the valuation front, i am on management's side - why show your hand of cards to your opponent?
edwardt
16/4/2018
19:26
Will plough through it when get the chance. And no doubt there is plenty to like and get excited about. However, i will say that I think it a mistake not to give some sort of guidance on valuation. It could be fairly generalised and not too portfolio company specific, if that's what they are worried about. As it is, for poor sods like me, who can't access the broker notes, it's going to be a struggle to value. In fact i (and i suspect the mkt) will be more conservative in valuations and focus more on any listed stuff ie TORC, or companies with known funding rounds. Ho humm...
rambutan2
16/4/2018
19:07
All 140 pages of it: htTp://puretechhealth.com/images/investors/PureTech-Health-ARA-2017_optimized-for-printing.pdf
rambutan2
16/4/2018
08:23
Results out now.
macarre
12/4/2018
18:58
Results were "planned" for today! The Group plans to issue its 2017 Annual Report and Results for the year ended 31 December 2017, based on its audited statutory accounts, on Thursday, 12 April 2018. hTtps://www.investegate.co.uk/puretech-health-plc--prtc-/rns/trading-statement/201802200700043301F/
rambutan2
10/4/2018
17:08
2017 annual report should be out in a few days if we judge from last year's release date. Which subsidiary makes you guys most excited about Puretech?
saleen230
21/3/2018
08:28
yep - got mine at 137 yesterday. rarely you get chance to get a better price on small caps than the big boys.
edwardt
20/3/2018
15:13
could n't resist a few more, my guess the raise has created a stock overhang.
edwardt
Chat Pages: 9  8  7  6  5  4  3  2  1
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V: D:20180526 19:53:26